Alzheimer’s-focused Peninsula biotech raises $100M


The company in May said it had completed recruitment of 140 mild to severe Alzheimer's patients for a mid-stage clinical trial.

Previous Kitzhaber is still trying to remake Oregon's health care system. Here's how.
Next VSP consolidating lens manufacturing, closing six labs nationwide